Statistics

Total Visits

Views
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies. 87

Total Visits per Month

December 2023 January 2024 February 2024 March 2024 April 2024 May 2024 June 2024
Safety and immunogenicity of a primary series and booster dose of the meningococcal serogroup B-factor H binding protein vaccine (MenB-FHbp) in healthy children aged 1-9 years: two phase 2 randomised, controlled, observer-blinded studies. 1 0 0 5 7 30 1

File Downloads

Views

Top Country Views

Views
United States 20
Hong Kong SAR China 12
Singapore 10
China 6
Vietnam 6
Belgium 5
Argentina 3
Australia 3
Ireland 3
France 2

Top City Views

Views
Hanoi 6
Singapore 6
Ashburn 5
Brussels 5
Boardman 3
Central 2
Clonee 2
Maurepas 2
Melbourne 2
Vitória da Conquista 1